Nintendo Switch 2 Production Cut as Holiday Sales Miss Targets 
Judge Dismisses Sam Altman Sexual Abuse Lawsuit, But Sister Can Refile 
Valero Port Arthur Refinery Explosion Prompts $1M Lawsuit Over Worker Safety Negligence 
Amazon's "Transformer" Phone: Can It Succeed Where Fire Phone Failed? 
Goldman Sachs Raises ECB Rate Hike Forecast Amid Persistent Energy-Driven Inflation 
SpaceX IPO Filing Expected This Week as Valuation Could Surpass $75 Billion 
NAB Plans to Cut 170 Jobs While Expanding Offshore Operations 
Apple Defies China's Smartphone Slump with Strong Early 2026 Sales 
Nanya Technology Shares Surge 10% After $2.5 Billion Private Placement from Sandisk and Cisco 
Super Micro Computer Shares Plunge After Co-Founder Charged in AI Chip Smuggling Case 
OpenAI Pulls the Plug on Sora, Ending $1 Billion Disney Partnership 
Cyberattack on Stryker Triggers U.S. Government Warning Over Microsoft Intune Security 
Jeff Bezos Eyes $100 Billion Fund to Transform Manufacturing With AI 
Delivery Hero Sells Taiwan Foodpanda to Grab for $600 Million in Debt-Reduction Push 
Trump White House Unveils National AI Policy Framework for Congress 
Microsoft Eyes Legal Action as Amazon-OpenAI Deal Threatens Azure Exclusivity 
SK Hynix Eyes Up to $14 Billion U.S. IPO to Fund AI Chip Expansion 
Alphabet Inc. is preparing to separate its life sciences subsidiary, Verily, in what could lead to a full sale or spinoff, according to recent testimony in a federal antitrust trial against Google. The move, revealed in court by Heather Adkins, Google’s Vice President of Security Engineering, marks the first public confirmation that Alphabet intends to divest Verily from its corporate structure.
Speaking in a Virginia courtroom, Adkins explained that Verily has been transitioning its operations from Google’s internal infrastructure to Google Cloud Platform for more than two years. This effort aims to make Verily technologically independent, a crucial step for any potential sale or spinoff. “We are in the process of helping them become an independent company,” Adkins stated. “The idea is to have it no longer be an Alphabet entity.”
Verily, launched as part of Alphabet’s push into health sciences, focuses on developing digital health solutions, data-driven research tools, and technologies that improve patient care. While Alphabet has previously worked to reduce Verily’s reliance on Google systems, Thursday’s testimony represents the clearest signal yet that Alphabet is preparing to cut ties with the unit.
The separation comes as Alphabet faces increased scrutiny over its dominance in digital advertising. The Justice Department’s case against Google centers on alleged monopolistic practices, and Adkins’ testimony offered a rare glimpse into Alphabet’s broader restructuring plans.
If Verily is spun off or sold, the move could reshape Alphabet’s portfolio by narrowing its focus on core businesses such as Google Search, YouTube, and cloud services, while positioning Verily to attract independent investors and partnerships in the rapidly growing health technology sector.
The potential spinoff underscores Alphabet’s evolving strategy of streamlining its business while allowing innovative subsidiaries like Verily to pursue independent growth paths in competitive industries.
